Enzyme Technology

Enzyme Technology appears to be a private early-stage biotechnology company based in Pudong, China, focused on AI-enabled enzymatic DNA synthesis. Publicly available information indicates the company was founded in 2023 and is developing a platform rather than a conventional therapeutic pipeline. Its positioning is more enabling-technology and synthetic biology infrastructure than drug developer, with potential applications across life science research and biomanufacturing. Available public data are sparse, and no clinical-stage therapeutic programs, named drug candidates, or disease-focused pipeline disclosures were identified in accessible sources.